Trump’s CBD Medicare signal sparks 36% boost in cannabis stocks — but should investors hold or brace for policy risks?

Group 1 - Cannabis investors experienced a surge of optimism after President Trump indicated support for covering CBD oil under Medicare, leading to stock price increases of up to 36% for companies like Green Thumb Industries, Curaleaf Holdings, Innovative Industrial Properties, Tilray Brands, and Canopy Growth [1][4] - The Commonwealth Project released a video promoting the benefits of CBD oil for seniors, which was shared by Trump on Truth Social, signaling potential support for Medicare coverage [1][3] - Despite the positive market reaction, there is no official confirmation or timeline regarding the reclassification of marijuana or Medicare coverage for CBD, leaving investors uncertain about future developments [2][4][5] Group 2 - The video shared by Trump emphasized the need for educating doctors on the endocannabinoid system and providing Medicare coverage for CBD, while also highlighting Trump's previous support through the 2018 Farm Bill [3] - The lack of explicit statements from Trump regarding his goals for CBD coverage under Medicare creates ambiguity for investors, suggesting that stock prices in the cannabis industry may remain volatile [4][5]